Trial Profile
A Randomised ,Double-Blind ,Parallel-Group Comparison of the Renal and Antihypertensive Effects of Telmisartan and Enalapril in Subjects With Mild to Moderate Hypertension and Concurrent Type II Diabetes Mellitus and Diabetic Nephropathy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Oct 2009
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Enalapril
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms DETAIL
- Sponsors Boehringer Ingelheim
- 29 Mar 2007 New trial record.